Patents by Inventor Kai Christoph WOLLERT

Kai Christoph WOLLERT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MYELOID-DERIVED GROWTH FACTOR FOR USE IN TREATING OR PREVENTING FIBROSIS, HYPERTROPHY OR HEART FAILURE
    Publication number: 20230059560
    Abstract: The present invention relates to the protein myeloid-derived growth factor (MYDGF) or nucleic acids encoding said protein for use in treating or preventing fibrosis and hypertrophy. The present invention also relates to the protein MYDGF or nucleic acids encoding said protein for use in treating heart failure. The present invention also relates to vectors comprising the nucleic acid, host cells expressing the nucleic acid, and methods for use in treating fibrosis and hypertrophy, and for use in treating heart failure.
    Type: Application
    Filed: January 19, 2021
    Publication date: February 23, 2023
    Inventors: Kai Christoph WOLLERT, Mortimer KORF-KLINGEBIEL, Marc R. REBOLL, Anton PEKCEC
  • Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
    Patent number: 10369198
    Abstract: The present invention relates to proteins comprising amino acid sequences encoded by nucleic acids derived from the human chromosomal region C19Orf10 termed Factor1 and/or C19Orf63 termed Factor 2 for the use in enhancing proliferation and/or healing and/or inhibiting apoptosis of none-transformed tissue or none-transformed cell or inhibitors thereof. The invention further relates to the use of inhibitors of factor1 and factor 2 for medical use, preferably for use in treating or preventing a disease in which angiogenesis contributes to disease development or progression.
    Type: Grant
    Filed: January 16, 2014
    Date of Patent: August 6, 2019
    Assignee: MEDIZINISCHE HOCHSCHULE HANNOVER
    Inventors: Kai Christoph Wollert, Mortimer Korf-Klingebiel
  • FACTOR 1 PROTEIN, FACTOR 2 PROTEIN AND INHIBITORS THEREOF FOR USE IN TREATING OR PREVENTING DISEASES
    Publication number: 20150352186
    Abstract: The present invention relates to proteins comprising amino acid sequences encoded by nucleic acids derived from the human chromosomal region C19Orf10 termed Factor1 and/or C19Orf63 termed Factor 2 for the use in enhancing proliferation and/or healing and/or inhibiting apoptosis of none-transformed tissue or none-transformed cell or inhibitors thereof. The invention further relates to the use of inhibitors of factor1 and factor 2 for medical use, preferably for use in treating or preventing a disease in which angiogenesis contributes to disease development or progression.
    Type: Application
    Filed: January 16, 2014
    Publication date: December 10, 2015
    Inventors: Kai Christoph WOLLERT, Mortimer KORF-KLINGEBIEL